August 3, 2025

PP2A activation drives aberrant macropinocytosis and cell death in pancreatic ductal adenocarcinoma

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Activation of PP2A inhibits macropinocytosis and promotes cell death in pancreatic ductal adenocarcinoma, suggesting a novel therapeutic approach.

PP2A activation reduces macropinosome processing, leading to increased cell death in pancreatic ductal adenocarcinoma.
Inhibition of macropinocytosis has been shown to decrease tumor growth, indicating its role in cancer cell survival.
The protein phosphatase 2A complex interacts with KRAS signaling, which is often mutated in pancreatic cancer.
Utilizing PP2A activating compounds may enhance the efficacy of existing metabolic inhibitors in treating this cancer.

Baral et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Activation of PP2A inhibits macropinocytosis and promotes cell death in pancreatic ductal adenocarcinoma, suggesting a novel therapeutic approach.